The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...

Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures, providing new hope for them and their ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...

Spasticity in multiple sclerosis was the most common condition cited by the doctors for treatment with medical cannabis, ...

The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...

"Why is it that patients who take prednisone, insulin...and a myriad of other medications daily or regularly to manage ...

New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...

For years, Texans living with conditions like PTSD, neuropathy, cancer and spasticity have had limited treatment options. Now ...

Spasticity in multiple sclerosis (MS) was the most common condition cited by the doctors for treatment with medical cannabis, followed by pain in MS and epilepsy. The study, published in the Irish ...

Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...